Blood Cancer Types, Stages, Symptoms and Blood Cancer Tests in Pune
Share
Persistent fatigue that sleep cannot fix, unexplained bruising, frequent infections, or painless swollen lymph nodes in the neck or armpit — these are among the earliest warning signs of blood cancer that are frequently dismissed as viral illness or stress. Blood cancer (haematological cancer) is a condition in which abnormal blood cells multiply uncontrollably, disrupting the normal production of healthy blood cells in the bone marrow — affecting immunity, oxygen transport, and clotting simultaneously. healthcare nt sickcare in Aundh, Pune offers comprehensive blood cancer detection tests with home sample collection and direct walk-in facility — making early-stage blood cancer screening accessible and affordable across Pune and Maharashtra.
Cancer Blood Tests in Pune
healthcare nt sickcare offers cancer blood tests in Pune with home sample collection and direct walk-in facility.
What Is Blood Cancer? Definition and How It Develops
Blood cancer is not a single disease — it is a group of cancers that originate in blood-forming tissues (bone marrow, lymph nodes, spleen) and disrupt the balanced production of red blood cells, white blood cells, and platelets that the body depends on for survival.
Micro-definition: Blood cancer (haematological malignancy) is defined as the abnormal, uncontrolled proliferation of immature or dysfunctional blood cells — most commonly originating in the bone marrow or lymphatic tissue — which crowd out normal healthy blood cells, impair immune function, and in advanced stages infiltrate other organs. According to the World Health Organisation, haematological cancers collectively account for approximately 6–8% of all cancers globally and disproportionately affect younger adults compared to most solid tumours.
Blood cancers are broadly classified into three main types — leukaemia, lymphoma, and myeloma — each with distinct subtypes, staging criteria, and treatment pathways. For a broader overview of all cancer types including solid tumours, read our complete guide on how to test for cancer and cancer marker tests.
Blood Cancer Types: Leukaemia, Lymphoma, and Myeloma Explained
The three primary types of blood cancer each arise from a different cell lineage in the blood and lymphatic system — requiring different diagnostic tests, staging systems, and treatment approaches.
1. Leukaemia — Cancer of the Blood and Bone Marrow
Micro-definition: Leukaemia is a cancer of the blood in which the bone marrow produces large numbers of abnormal, immature white blood cells (blast cells) that cannot fight infection effectively and crowd out normal red blood cells and platelets — causing anaemia, susceptibility to infection, and bleeding problems.
Leukaemia is classified by the rate of progression (acute vs. chronic) and the type of white blood cell affected (myeloid vs. lymphoid):
- Acute Lymphoblastic Leukaemia (ALL) — The most common blood cancer in children in India; also affects adults; rapid onset with high blast cell counts; very aggressive but highly responsive to chemotherapy in children (cure rates above 85%)
- Acute Myeloid Leukaemia (AML) — More common in adults above 60; rapid progression from normal blood counts to crisis within weeks; requires immediate intensive chemotherapy
- Chronic Lymphocytic Leukaemia (CLL) — The most common adult leukaemia worldwide; slow progression; often detected incidentally on a routine CBC; may require years of watchful waiting before treatment
- Chronic Myeloid Leukaemia (CML) — Caused in over 95% of cases by the Philadelphia chromosome (BCR-ABL gene fusion); responds remarkably well to targeted tyrosine kinase inhibitors (e.g., imatinib); detectable by the BCR-ABL genetic test
2. Lymphoma — Cancer of the Lymphatic System
Micro-definition: Lymphoma is a cancer that begins in lymphocytes (a type of white blood cell) within the lymph nodes, spleen, thymus, or bone marrow — presenting most characteristically as painless enlarged lymph nodes in the neck, armpit, or groin.
- Hodgkin Lymphoma (HL) — Characterised by the presence of Reed-Sternberg cells on biopsy; highly curable even at advanced stages with chemotherapy and radiation; affects young adults (age 20–35) and older adults (above 55) most commonly
- Non-Hodgkin Lymphoma (NHL) — A diverse group of over 60 lymphoma subtypes; ranges from indolent (slow-growing) to highly aggressive; B-cell lymphomas are more common than T-cell lymphomas; Diffuse Large B-Cell Lymphoma (DLBCL) is the most common NHL subtype in India
3. Multiple Myeloma — Cancer of Plasma Cells
Micro-definition: Multiple myeloma is a blood cancer of plasma cells (antibody-producing B-cells) in the bone marrow that accumulate abnormally, producing abnormal proteins (M-protein or paraprotein) that damage kidneys, weaken bones, and suppress normal antibody production — making patients highly susceptible to infections and fractures.
Multiple myeloma most commonly presents in adults above 60 with bone pain (especially back pain), recurrent infections, fatigue from anaemia, and kidney dysfunction. It is detected through serum protein electrophoresis, immunoglobulin quantification, and the Beta-2 microglobulin test. Read our guide on how to test for anaemia — a primary symptom of all three blood cancer types.
Blood Cancer Stages: How Each Type Is Staged
Blood cancer staging determines the extent of disease spread, guides treatment intensity, and predicts prognosis — but staging systems differ significantly between leukaemia, lymphoma, and myeloma.
Leukaemia Staging
Acute leukaemias (ALL and AML) do not follow the conventional Stage I–IV system. Instead, they are classified by blast cell percentage in bone marrow and blood, cytogenetic risk (favourable, intermediate, or adverse chromosome changes), and treatment response after induction chemotherapy. The International Prognostic Scoring System (IPSS) is used for myelodysplastic syndromes progressing to AML. Chronic leukaemias use separate scoring systems — CLL uses the Rai or Binet staging (Stage 0–IV based on lymphocyte count, lymph node enlargement, spleen size, and anaemia/thrombocytopenia), while CML uses the Sokal and EUTOS scores based on blast percentage, spleen size, and platelet count.
Lymphoma Staging (Ann Arbor System)
| Stage | Description | Typical Findings |
|---|---|---|
| Stage I | Single lymph node region or single extralymphatic site | One enlarged lymph node group; localised; highly curable |
| Stage II | Two or more lymph node regions on the same side of the diaphragm | Multiple node groups; neck + armpit on same side; still localised |
| Stage III | Lymph node regions on both sides of the diaphragm involved | Both above and below chest; may include spleen; combination therapy required |
| Stage IV | Diffuse involvement of one or more extralymphatic organs (liver, bone marrow, lungs) | Widespread disease; bone marrow biopsy confirms; intensive systemic treatment |
B symptoms — unexplained fever above 38°C, drenching night sweats, and weight loss of more than 10% in 6 months — are added as suffix "B" to the stage and indicate more aggressive disease requiring intensified treatment.
Multiple Myeloma Staging (Revised ISS)
- Stage I (R-ISS) — Serum Beta-2 microglobulin below 3.5 mg/L, albumin above 3.5 g/dL, no high-risk cytogenetics, normal LDH; best prognosis (median survival above 5 years)
- Stage II (R-ISS) — Neither Stage I nor Stage III criteria met; intermediate prognosis
- Stage III (R-ISS) — Beta-2 microglobulin above 5.5 mg/L plus either high-risk chromosomal abnormalities or elevated LDH; worst prognosis (median survival approximately 2 years without novel agents)
Blood Cancer Symptoms: Early and Late Stage Warning Signs
Blood cancer symptoms result directly from the failure of normal blood cell production — causing anaemia (too few red blood cells), neutropenia (too few neutrophils for infection-fighting), and thrombocytopenia (too few platelets for clotting).
First Stage Blood Cancer Symptoms
Early-stage blood cancer symptoms are non-specific and frequently attributed to stress, viral infections, or nutritional deficiency — which is why routine blood testing is the only reliable way to differentiate them.
- Persistent, unexplained fatigue — Not relieved by rest or sleep; caused by anaemia from bone marrow crowding; the single most consistent early symptom across all blood cancer types
- Recurrent infections and prolonged fevers — Abnormal white blood cells cannot fight pathogens; infections that are unusually frequent, severe, or slow to resolve warrant immediate CBC investigation
- Unexplained bruising or bleeding — Small bruises from minor contact, prolonged bleeding from cuts, bleeding gums, or petechiae (tiny red-purple spots under skin) indicate low platelet counts
- Painless swollen lymph nodes — Enlarged nodes in the neck, armpit, or groin that persist for more than 2 weeks without associated infection are a classic lymphoma presentation
- Shortness of breath on exertion — Anaemia reduces oxygen-carrying capacity; even mild activity causes breathlessness
- Bone or joint pain — Particularly in the sternum, ribs, spine, and long bones; caused by expansion of abnormal cells in bone marrow or myeloma deposits in bone
- Pallor — Pale skin, pale conjunctivae, and pale nail beds from anaemia
Advanced Stage Blood Cancer Symptoms
As blood cancer progresses, systemic involvement produces more severe and unmistakable symptoms requiring urgent specialist intervention.
- Drenching night sweats — Soaking nightwear without fever; a B symptom in lymphoma staging; also common in advanced leukaemia
- Significant unintended weight loss — Loss of more than 10% of body weight over 6 months without dietary change
- Abdominal swelling or fullness — Caused by splenomegaly (enlarged spleen) or hepatomegaly (enlarged liver) from cancer cell infiltration
- Persistent high fever without infection — Tumour-related fever (B fever) in lymphoma and leukaemia
- Neurological symptoms — Headaches, dizziness, blurred vision, and confusion indicate central nervous system involvement (CNS leukaemia or lymphoma)
- Skin changes — Purpura, skin rashes, or specific skin infiltrates (cutaneous lymphoma)
- Back pain with bone fractures — Myeloma-related vertebral fractures from osteolytic (bone-destroying) lesions; hypercalcaemia causes nausea, constipation, and confusion
- Kidney dysfunction — Myeloma proteins (Bence Jones proteins) damage renal tubules; elevated creatinine and proteinuria
Book Medical Lab Testing in Pune
healthcare nt sickcare offers medical lab tests and preventive health checkup packages testing with home sample collection and direct walk-in facility.
How to Test for Blood Cancer? Blood Tests and Diagnostic Panels
Blood cancer testing begins with a Complete Blood Count (CBC) — the most accessible and affordable first-line investigation — followed by specialist confirmatory tests when abnormalities are detected.
Complete Blood Count (CBC) — First-Line Blood Cancer Screening Test
The CBC is the most important and widely used initial test for detecting blood cancer — providing a complete count and morphological profile of all three blood cell types in a single blood draw.
CBC findings that may indicate blood cancer include: elevated white blood cell count above 100,000/µL (severe leukocytosis — classic in leukaemia); very low white blood cell count below 2,000/µL (leukopenia — bone marrow suppression); haemoglobin below 8 g/dL with normal iron stores (normocytic normochromic anaemia — bone marrow infiltration); platelet count below 50,000/µL (severe thrombocytopenia); and the simultaneous drop in all three cell lines (pancytopenia — strongly suggests bone marrow failure or infiltration). Book the Complete Blood Count (Haemogram) or the combined CBC + ESR for comprehensive initial blood cancer screening. Browse the full CBC blood tests collection in Pune.
Peripheral Blood Smear — Microscopic Blood Cell Examination
The peripheral blood smear examines blood cell morphology (size, shape, and maturity) under a microscope — detecting blast cells, Reed-Sternberg cells, abnormal lymphocytes, and other malignant cell forms invisible on automated CBC alone. Book the Peripheral Blood Smear Test when CBC shows unexplained abnormalities or when blood cancer is suspected.
Specific Blood Cancer Marker Tests
| Test | Blood Cancer Type | What It Measures | Book at HNSC |
|---|---|---|---|
| LDH (Lactate Dehydrogenase) | Lymphoma, leukaemia, myeloma | Tumour burden marker; elevated in active disease and aggressive subtypes | LDH Test |
| Beta-2 Microglobulin | Multiple myeloma, CLL, lymphoma | Staging and prognosis marker; elevated in high tumour burden | Beta-2 Microglobulin |
| Serum Protein Electrophoresis (SPEP) | Multiple myeloma | Detects M-protein (paraprotein) band — diagnostic for myeloma | Protein Electrophoresis |
| Immunoglobulins (IgG, IgA, IgM) | Myeloma, Waldenström's, lymphoma | Quantifies immunoglobulin levels; elevated or suppressed in specific myeloma subtypes | IgG / IgA / IgM |
| Uric Acid | Leukaemia, lymphoma (tumour lysis syndrome) | Elevated in rapid cell turnover; critical monitoring marker during chemotherapy | Uric Acid Test |
| ESR (Erythrocyte Sedimentation Rate) | Lymphoma, myeloma, leukaemia | Non-specific marker of systemic inflammation; markedly elevated in active lymphoma and myeloma | ESR Test |
| Ferritin | Leukaemia, lymphoma, haemophagocytic syndrome | Very high ferritin (hyperferritinaemia) is a marker of haematological malignancy activity | Ferritin Test |
| Reticulocyte Count | Bone marrow failure, aplastic anaemia, leukaemia | Low reticulocyte count with anaemia indicates bone marrow is not producing new red cells | Reticulocyte Count |
| Vitamin B12 and Folic Acid | Differentiates from nutritional macrocytic anaemia | Rules out B12/folate deficiency as cause of high MCV and abnormal CBC before pursuing cancer workup | Vitamin B12 / Folic Acid |
For a comprehensive initial blood cancer screening panel, book the Advanced Anaemia Profile Test or the Complete Anaemia Profile — both cover CBC, reticulocyte count, iron studies, B12, folic acid, and peripheral smear in a single booking. If thalassaemia trait is suspected as a differential, the Thalassaemia Profile Test helps rule this out. Explore all cancer tests and packages.
Learn about the advancements in medical laboratory techniques used in blood cancer diagnosis and the most common blood tests ordered in India. Review our test preparation guides before your blood cancer panel booking.
Blood Cancer Causes and Risk Factors
Blood cancer arises when accumulated genetic mutations in a single blood stem cell trigger uncontrolled division — with the following factors increasing the probability of those mutations occurring.
- Radiation exposure — Ionising radiation (X-rays, CT scans, nuclear radiation) is a proven leukaemia risk factor; survivors of atomic bomb exposure showed markedly elevated leukaemia rates within 2–10 years
- Chemical exposure — Benzene (found in petrol, paint thinners, cigarette smoke) is the most established occupational cause of AML and ALL; prolonged exposure in manufacturing and printing industries increases risk
- Previous chemotherapy — Alkylating agents and topoisomerase II inhibitors used to treat prior cancers can cause therapy-related AML (t-AML) 3–7 years after treatment
- Inherited genetic syndromes — Down syndrome (Trisomy 21) carries a 10–20x elevated leukaemia risk; Fanconi anaemia, Bloom syndrome, and ataxia-telangiectasia all significantly elevate blood cancer risk
- Viral infections — Epstein-Barr Virus (EBV) causes Burkitt lymphoma and Hodgkin lymphoma; HTLV-1 (Human T-lymphotropic virus) causes adult T-cell leukaemia/lymphoma; HIV increases lymphoma risk 60–100 fold
- Immune suppression — Organ transplant recipients on long-term immunosuppressants and HIV-positive individuals have markedly elevated lymphoma risk
- Age and sex — Most blood cancers increase in incidence with age; CLL and myeloma are predominantly diseases of adults above 60; ALL is more common in children; men are affected more than women in most blood cancer subtypes
- Family history — First-degree relatives of CLL patients have a 2–7x elevated risk; familial myeloma clusters are documented though most cases are sporadic
People Also Ask About Blood Cancer Types, Stages, and Tests
Yes — a routine Complete Blood Count (CBC) is the most important first-line test for detecting blood cancer, though it cannot provide a definitive diagnosis alone. CBC abnormalities that strongly suggest blood cancer include: very high white blood cell counts above 50,000–100,000/µL (severe leukocytosis — typical of acute leukaemia); very low counts across all cell lines simultaneously (pancytopenia — suggests bone marrow failure or infiltration); unexplained severe anaemia (Hb below 8 g/dL) with normal iron stores; platelet counts below 50,000/µL without obvious cause; and the presence of immature blast cells reported on the differential count. When a CBC shows these abnormalities, specialist haematology referral for bone marrow aspiration and biopsy, flow cytometry, and genetic testing is the standard next step. healthcare nt sickcare in Pune offers CBC with peripheral smear, LDH, Beta-2 microglobulin, and comprehensive anaemia profiles with home sample collection and results within 24–48 hours.
The first signs of leukaemia in adults are often non-specific and easily overlooked for weeks or months before diagnosis. The most common early symptoms include: persistent fatigue and weakness not relieved by rest (caused by anaemia from bone marrow crowding); frequent infections — particularly respiratory tract infections — that are unusually severe or take longer than normal to resolve (caused by dysfunctional white blood cells); unexplained bruising from minor contact or spontaneous bruising with no trauma (caused by low platelets); small red or purple spots on skin called petechiae (caused by platelet deficiency); bone or joint pain, particularly in the sternum and long bones; and mild but persistent fever without an obvious infection. In chronic leukaemia (CLL, CML), the disease may be entirely asymptomatic for years and detected only on a routine CBC showing elevated white blood cell counts. A CBC with differential and peripheral blood smear at healthcare nt sickcare in Pune — available with home collection — is the first investigation step when these symptoms persist.
Leukaemia, lymphoma, and myeloma are all blood cancers but arise from different cell types and locations. Leukaemia originates in the bone marrow and involves abnormal production of white blood cells (blast cells) that flood the bloodstream — causing anaemia, bleeding, and infection risk; detected primarily by CBC and bone marrow biopsy. Lymphoma originates in lymphocytes within lymph nodes or lymphatic organs — presenting most commonly as painless enlarged lymph nodes; divided into Hodgkin lymphoma (curable in over 80% of cases) and Non-Hodgkin lymphoma (diverse group with variable prognosis); detected by LDH, CBC, and node biopsy. Multiple myeloma originates in plasma cells within bone marrow — producing abnormal antibody proteins (M-protein) that damage kidneys and weaken bones; detected by serum protein electrophoresis, immunoglobulin levels, Beta-2 microglobulin, and bone marrow biopsy. Each requires different staging systems, treatment regimens, and follow-up blood test panels.
Blood cancer treatment monitoring requires a combination of tests repeated at regular intervals (typically every 4–8 weeks during treatment and every 3–6 months during remission). Key monitoring tests include: CBC with differential — the primary response indicator showing normalisation of blood cell counts; LDH (Lactate Dehydrogenase) — falling LDH confirms tumour burden reduction in lymphoma and leukaemia; Beta-2 microglobulin — used to monitor myeloma and CLL treatment response; serum protein electrophoresis and immunoglobulin quantification — for monitoring M-protein clearance in myeloma; uric acid — monitored closely during initial chemotherapy to detect tumour lysis syndrome; liver function tests (LFT) and kidney function tests (KFT) — for chemotherapy toxicity monitoring; and specific genetic markers (BCR-ABL PCR) for CML patients on targeted therapy to assess molecular remission. All these tests are available at healthcare nt sickcare in Pune with home collection and reports within 24–48 hours.
Blood tests are highly effective for detecting and monitoring haematological (blood and lymphatic) cancers — leukaemia, lymphoma, and myeloma — but are generally insufficient to diagnose most solid tumours without imaging and biopsy. Cancers that cannot be reliably detected by blood tests alone include: breast cancer (requires mammogram, ultrasound, and biopsy; CA 15-3 is a monitoring marker, not a screening tool); lung cancer (requires CT scan and bronchoscopy; CYFRA 21-1 aids staging but not primary screening); colon cancer (colonoscopy remains the gold standard; CEA is a monitoring marker); brain tumours (require MRI and surgical biopsy); skin cancer (requires dermatoscopy and skin biopsy); and thyroid cancer (requires ultrasound and fine needle aspiration cytology). Multi-cancer early detection blood tests (liquid biopsy — circulating tumour DNA panels) are an emerging technology and are not yet widely available or validated for clinical use in India. For solid tumour cancer screening, read our comprehensive guide on how to test for cancer using cancer marker tests.
The accuracy of blood tests for blood cancer detection varies by the specific test and cancer type. The CBC is highly sensitive for detecting leukaemia when blast cells exceed 20% in peripheral blood — the diagnostic threshold for acute leukaemia — with near 100% sensitivity in overt disease. However, in early chronic leukaemias (Stage 0 CLL), the CBC may show only mild lymphocytosis that could be misattributed to a viral infection. LDH and Beta-2 microglobulin are elevated in 60–80% of lymphoma cases but are not specific to cancer alone. Serum protein electrophoresis has 80–90% sensitivity for detecting IgG and IgA myeloma but may miss IgD and light chain myeloma subtypes. Importantly, no single blood test can definitively diagnose blood cancer — positive results always require confirmation through bone marrow aspiration and biopsy, flow cytometry, and cytogenetic/molecular genetic testing performed by a specialist haematologist. Blood tests available at healthcare nt sickcare provide the critical first step that determines whether specialist referral is necessary.
Several types of blood cancer are curable — particularly when detected early — while others are manageable as chronic conditions with excellent long-term survival on targeted therapy. Hodgkin Lymphoma has a cure rate above 85% even in advanced stages with modern chemotherapy and radiation. Acute Lymphoblastic Leukaemia (ALL) in children has a cure rate of 85–90% in specialised paediatric oncology centres in India. Chronic Myeloid Leukaemia (CML) has been transformed from a rapidly fatal disease to a chronic manageable condition by targeted tyrosine kinase inhibitors (imatinib) — with 10-year survival rates above 80%. Multiple myeloma remains incurable but median survival has improved to 5–7 years with novel agents (proteasome inhibitors, immunomodulators, anti-CD38 antibodies, and autologous stem cell transplant). Acute Myeloid Leukaemia (AML) in adults remains the most challenging — overall 5-year survival is approximately 25–30%, though younger patients with favourable cytogenetics can achieve cure with intensive chemotherapy. Early detection through regular CBC at healthcare nt sickcare in Pune — available with home collection — remains the single most important factor in improving blood cancer outcomes.
Take the Next Step with healthcare nt sickcare
Blood cancer detected early is blood cancer most successfully treated. If you or a family member have persistent fatigue, unexplained bruising, swollen lymph nodes, or recurrent infections — do not wait. Book a CBC, peripheral smear, and LDH at healthcare nt sickcare in Pune today — home collection across all major areas, NABL-accredited results, no prescription needed.
Disclaimer
All material copyright healthcare nt sickcare. Terms and Conditions and Privacy Policy of use apply. The contents of this article are for public health awareness and informational purposes only. Blood cancer diagnosis, staging, and treatment require evaluation by a qualified haematologist or oncologist. Abnormal blood test results must be interpreted in clinical context and do not constitute a cancer diagnosis. Always consult your doctor for personalised medical advice. Visit our patient resources page for further guidance.
Images in this article are AI-generated using Google Gemini and Shopify Magic. © healthcare nt sickcare and healthcarentsickcare.com, 2017–Present. Unauthorised use or duplication without express written permission is strictly prohibited.